399 related articles for article (PubMed ID: 25772061)
1. GPCR structure, function, drug discovery and crystallography: report from Academia-Industry International Conference (UK Royal Society) Chicheley Hall, 1-2 September 2014.
Heifetz A; Schertler GF; Seifert R; Tate CG; Sexton PM; Gurevich VV; Fourmy D; Cherezov V; Marshall FH; Storer RI; Moraes I; Tikhonova IG; Tautermann CS; Hunt P; Ceska T; Hodgson S; Bodkin MJ; Singh S; Law RJ; Biggin PC
Naunyn Schmiedebergs Arch Pharmacol; 2015 Aug; 388(8):883-903. PubMed ID: 25772061
[TBL] [Abstract][Full Text] [Related]
2. Structural insights into ligand recognition and selectivity for classes A, B, and C GPCRs.
Lee SM; Booe JM; Pioszak AA
Eur J Pharmacol; 2015 Sep; 763(Pt B):196-205. PubMed ID: 25981303
[TBL] [Abstract][Full Text] [Related]
3. Class A GPCRs: Structure, Function, Modeling and Structure-based Ligand Design.
Cong X; Topin J; Golebiowski J
Curr Pharm Des; 2017 Nov; 23(29):4390-4409. PubMed ID: 28699533
[TBL] [Abstract][Full Text] [Related]
4. The impact of GPCR structures on pharmacology and structure-based drug design.
Congreve M; Marshall F
Br J Pharmacol; 2010 Mar; 159(5):986-96. PubMed ID: 19912230
[TBL] [Abstract][Full Text] [Related]
5. Structure determination of GPCRs: cryo-EM compared with X-ray crystallography.
García-Nafría J; Tate CG
Biochem Soc Trans; 2021 Nov; 49(5):2345-2355. PubMed ID: 34581758
[TBL] [Abstract][Full Text] [Related]
6. X-ray structure breakthroughs in the GPCR transmembrane region.
Topiol S; Sabio M
Biochem Pharmacol; 2009 Jul; 78(1):11-20. PubMed ID: 19447219
[TBL] [Abstract][Full Text] [Related]
7. G proteins in drug screening: from analysis of receptor-G protein specificity to manipulation of GPCR-mediated signalling pathways.
Kostenis E
Curr Pharm Des; 2006; 12(14):1703-15. PubMed ID: 16712483
[TBL] [Abstract][Full Text] [Related]
8. GPCR crystal structures: Medicinal chemistry in the pocket.
Shonberg J; Kling RC; Gmeiner P; Löber S
Bioorg Med Chem; 2015 Jul; 23(14):3880-906. PubMed ID: 25638496
[TBL] [Abstract][Full Text] [Related]
9. Established and In-trial GPCR Families in Clinical Trials: A Review for Target Selection.
Saikia S; Bordoloi M; Sarmah R
Curr Drug Targets; 2019; 20(5):522-539. PubMed ID: 30394207
[TBL] [Abstract][Full Text] [Related]
10. Pharmacology of Free Fatty Acid Receptors and Their Allosteric Modulators.
Grundmann M; Bender E; Schamberger J; Eitner F
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33578942
[TBL] [Abstract][Full Text] [Related]
11. Discovery of GPCR Ligands by Molecular Docking Screening: Novel Opportunities Provided by Crystal Structures.
Rodríguez D; Ranganathan A; Carlsson J
Curr Top Med Chem; 2015; 15(24):2484-503. PubMed ID: 26126906
[TBL] [Abstract][Full Text] [Related]
12. Molecular modeling of vasopressin receptor and in silico screening of V1b receptor antagonists.
Hagiwara Y; Ohno K; Kamohara M; Takasaki J; Watanabe T; Fukunishi Y; Nakamura H; Orita M
Expert Opin Drug Discov; 2013 Aug; 8(8):951-64. PubMed ID: 23682717
[TBL] [Abstract][Full Text] [Related]
13. Recent Advances in Structure-Based Drug Design Targeting Class A G Protein-Coupled Receptors Utilizing Crystal Structures and Computational Simulations.
Lee Y; Basith S; Choi S
J Med Chem; 2018 Jan; 61(1):1-46. PubMed ID: 28657745
[TBL] [Abstract][Full Text] [Related]
14. Cryo-electron microscopy for GPCR research and drug discovery in endocrinology and metabolism.
Duan J; He XH; Li SJ; Xu HE
Nat Rev Endocrinol; 2024 Jun; 20(6):349-365. PubMed ID: 38424377
[TBL] [Abstract][Full Text] [Related]
15. Emerging Approaches to GPCR Ligand Screening for Drug Discovery.
Kumari P; Ghosh E; Shukla AK
Trends Mol Med; 2015 Nov; 21(11):687-701. PubMed ID: 26481827
[TBL] [Abstract][Full Text] [Related]
16. Efficiency of Homology Modeling Assisted Molecular Docking in G-protein Coupled Receptors.
Bhunia SS; Saxena AK
Curr Top Med Chem; 2021; 21(4):269-294. PubMed ID: 32901584
[TBL] [Abstract][Full Text] [Related]
17. New paradigms in GPCR drug discovery.
Jacobson KA
Biochem Pharmacol; 2015 Dec; 98(4):541-55. PubMed ID: 26265138
[TBL] [Abstract][Full Text] [Related]
18. Thematic Minireview Series: New Directions in G Protein-coupled Receptor Pharmacology.
Dohlman HG
J Biol Chem; 2015 Aug; 290(32):19469-70. PubMed ID: 26126823
[TBL] [Abstract][Full Text] [Related]
19. Allosteric binding sites at the receptor-lipid bilayer interface: novel targets for GPCR drug discovery.
Wang Y; Yu Z; Xiao W; Lu S; Zhang J
Drug Discov Today; 2021 Mar; 26(3):690-703. PubMed ID: 33301977
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in the determination of G protein-coupled receptor structures.
Thal DM; Vuckovic Z; Draper-Joyce CJ; Liang YL; Glukhova A; Christopoulos A; Sexton PM
Curr Opin Struct Biol; 2018 Aug; 51():28-34. PubMed ID: 29547818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
